Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
By D. Cooper, Gerard M Doherty, B. Haugen, R. Kloos, Stephanie L. Lee, S. Mandel, E. Mazzaferri, B. Mciver, F. Pacini, M. Schlumberger and 3 more. Thyroid, 2009
8,052 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Surgery
View Paper: https://www.semanticscholar.org/paper/66ce9f3a73bc3e2edb795b17a7e10d2b803e92c6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Surgery
Citations in the corpus
- American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer (2012, neutral): “The American Thyroid Association (ATA) has a history of supporting the development of guidelines for the care of patients with thyroid disease.* This includes several guidelines for management of DTC (4–6) and recent first MTC guidelines (7).”
- Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014, neutral): “LT3 therapy started after LT4 discontinuation, usually administered at a dose of 25 lg twice daily, has traditionally been used with the intent of ameliorating hypothyroid symptoms in situations in which induction of hypothyroidism was used as a means delivering therapy for thyroid cancer (544).”
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer (2009, neutral): “ATA Thyroid Nodules and Differentiated Thyroid Cancer guidelines were published in 2006 (24) and revised in 2009 (25).”
- The Prognostic Significance of Nodal Metastases from Papillary Thyroid Carcinoma Can Be Stratified Based on the Size and Number of Metastatic Lymph Nodes, as Well as the Presence of Extranodal Extension (2012, neutral): “It is important to note that despite having a very high risk of harboring subclinical, microscopic locoregional disease, patients with PMC are considered low-risk patients (4,21,22).”